Investigational Site Number : 1240001

Sherbrooke, Quebec J1L 0H8

1 studies enrolling now · 2 studies all time

What they study most

Immunoglobulin G4 Related Disease, Sjogren's Syndrome, Sjögren's Syndrome

Studies at this site

• A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease — Recruiting now
• Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) — Completed